About: MMDA-2

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: MMDA-2 Goto Sponge NotDistinct Permalink

An Entity of Type : yago:WikicatPhenolEthers, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMMDA-2

MMDA-2 (2-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic drug of the amphetamine class. It is closely related to MMDA and MDA. Alexander Shulgin was likely the first to synthesize MMDA-2. In his book PiHKAL, the dose is listed as 25–50 mg, and the duration is listed as 8–12 hours. Shulgin reports that MMDA-2 produces effects such as enhanced awareness, empathy, and visual facilitation and distortion, as well as some side effects like gastrointestinal upset and appetite loss. He states that 30 mg is very similar to 80 mg of MDA, and also remarks that it would be impossible for anyone to have a bad experience on the drug at that dose.

Attributes	Values
rdf:type	Thing dul:ChemicalObject chemical substance Drug yago:Abstraction100002137 yago:Element114840755 yago:Matter100020827 yago:Part113809207 yago:PhysicalEntity100001930 yago:Quintessence114847103 yago:Relation100031921 drug yago:Substance100019613 yago:WikicatPhenolEthers
rdfs:label	MMDA-2 (it) MMDA-2 (en)
rdfs:comment	MMDA-2 (noto anche come 2-metossi-4,5-metilendiossiametamina) è un farmaco psichedelico appartenente alla classe delle anfetamine, chimicamente simile alle MMDA e MDA. (it) MMDA-2 (2-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic drug of the amphetamine class. It is closely related to MMDA and MDA. Alexander Shulgin was likely the first to synthesize MMDA-2. In his book PiHKAL, the dose is listed as 25–50 mg, and the duration is listed as 8–12 hours. Shulgin reports that MMDA-2 produces effects such as enhanced awareness, empathy, and visual facilitation and distortion, as well as some side effects like gastrointestinal upset and appetite loss. He states that 30 mg is very similar to 80 mg of MDA, and also remarks that it would be impossible for anyone to have a bad experience on the drug at that dose. (en)
foaf:depiction
dcterms:subject	Benzodioxoles Designer drugs Entactogens and empathogens Phenol ethers Serotonin receptor agonists Substituted amphetamines
Wikipage page ID	11110649 (xsd:integer)
Wikipage revision ID	1097241292 (xsd:integer)
Link from a Wikipage to another Wikipage	6-methyl-MDA Mouth Designer drug United States Insufflation (medicine) Substituted amphetamine Psychedelic drug Benzodioxoles Designer drugs Entactogens and empathogens Phenol ethers Serotonin receptor agonists Chemical synthesis Rectal Empathy Drug 3,4-Methylenedioxyamphetamine Agonist Alexander Shulgin Amphetamine 5-HT2A receptor 5-HT2 receptor DOx Federal Analogue Act Substituted amphetamines Japan Abdominal pain dbr:Dopamine Awareness Appetite loss Mental imagery dbr:Serotonin Side effect PiHKAL 3-methoxy-4,5-methylenedioxyamphetamine Visual distortion
Link from a Wikipage to an external page	http://www.erowid.org/library/books_online/pihkal/pihkal133.shtml http://isomerdesign.com/PiHKAL/read.php%3Fdomain=pk&id=133
sameAs	MMDA-2 MMDA-2 MMDA-2 MMDA-2 MMDA-2 MMDA-2 MMDA-2 MMDA-2
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Entactogens dbt:Phenethylamines dbt:Reflist dbt:Serotonergics dbt:Short_description dbt:Fdacite
thumbnail	wiki-commons:Special:FilePath/MMDA-2-structure.png?width=300
ATC prefix	none (en)
c	11 (xsd:integer)
CAS number	23693 (xsd:integer)
ChemSpiderID	82147 (xsd:integer)
H	15 (xsd:integer)
IUPAC name	1 (xsd:integer)
legal DE	NpSG (en)
legal status	Uncontrolled (en)
legal UK	Class A (en)
n	1 (xsd:integer)
O	3 (xsd:integer)
PubChem	90966 (xsd:integer)
routes of administration	Mouth Insufflation (medicine) Rectal
SMILES	O1c2ccCCC (en)
UNII	TG0B6ER184 (en)
has abstract	MMDA-2 (2-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic drug of the amphetamine class. It is closely related to MMDA and MDA. Alexander Shulgin was likely the first to synthesize MMDA-2. In his book PiHKAL, the dose is listed as 25–50 mg, and the duration is listed as 8–12 hours. Shulgin reports that MMDA-2 produces effects such as enhanced awareness, empathy, and visual facilitation and distortion, as well as some side effects like gastrointestinal upset and appetite loss. He states that 30 mg is very similar to 80 mg of MDA, and also remarks that it would be impossible for anyone to have a bad experience on the drug at that dose. Scientific research has shown that MMDA-2, unlike MMDA, but similarly to 6-methyl-MDA, is only very weak at inducing the release of serotonin or dopamine, and accordingly, does not produce amphetamine-like responses in animals in drug discrimination studies. Instead, MMDA-2 is likely to act as a pure 5-HT2 receptor agonist similarly to the DOx series of compounds, with activation of the 5-HT2A receptor conferring its psychedelic effects. MMDA-2 has been sold as a designer drug in Japan. (en) MMDA-2 (noto anche come 2-metossi-4,5-metilendiossiametamina) è un farmaco psichedelico appartenente alla classe delle anfetamine, chimicamente simile alle MMDA e MDA. (it)

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 54 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software